MARKET

CSCI

CSCI

Cosciens Biopharma
NASDAQ
3.000
+0.110
+3.81%
Closed 16:00 01/17 EST
OPEN
2.900
PREV CLOSE
2.890
HIGH
3.130
LOW
2.890
VOLUME
5.45K
TURNOVER
--
52 WEEK HIGH
11.10
52 WEEK LOW
2.500
MARKET CAP
9.37M
P/E (TTM)
-0.3849
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CSCI last week (0113-0117)?
Weekly Report · 6h ago
Weekly Report: what happened at CSCI last week (0106-0110)?
Weekly Report · 01/13 10:53
Weekly Report: what happened at CSCI last week (1230-0103)?
Weekly Report · 01/06 10:59
Weekly Report: what happened at CSCI last week (1223-1227)?
Weekly Report · 12/30/2024 10:54
COSCIENS Biopharma halts investment in macimorelin; CMO to depart
Seeking Alpha · 12/23/2024 13:49
COSCIENS Biopharma Focuses on Natural Product Growth
TipRanks · 12/23/2024 13:07
Cosciens Biopharma provides update, reiterates pipeline prioritization
TipRanks · 12/23/2024 12:50
COSCIENS Biopharma Shifts Focus to Natural-Based Products for Health & Wellness
Benzinga · 12/23/2024 12:46
More
About CSCI
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

Webull offers COSCIENS Biopharma Inc (USA) stock information, including NASDAQ: CSCI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSCI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSCI stock methods without spending real money on the virtual paper trading platform.